S udden cardiac arrest related to ventricular arrhythmias is a major cause of mortality in the United States, accounting for over 500,000 deaths annually (1) . The vast majority of patients suffering sudden cardiac arrest have evidence of coronary heart disease and up to 15-64% have evidence of recent coronary occlusion (2) . Therapeutic hypothermia (TH) (cooling to 32-34°C) has now become the standard of care for patients who suffer cardiac arrest and have subsequent return of spontaneous circulation (3) (4) (5) . The most recent Advanced Cardiac Life Support Guidelines recommends induction of TH after return of spontaneous circulation both after ventricular fibrillation (VF) arrest (class I, LOE B) and pulseless electrical activity/asystole (class IIb, LOE C) (6) .
However, hypothermia is arrhythmogenic. Arrhythmias are encountered in the majority of patients with severe hypothermia (<30°C), including VF that can be refractory to standard therapy (7, 8) . Hypothermia prolongs action potential duration (APD), resulting in prolongation of the QT interval because currents governing repolarization are particularly susceptible to hypothermia (9) (10) (11) (12) (13) . Importantly, hypothermia increases trans mural dispersion of repolarization (DOR), a well-known prerequisite for reentrant excitation and arrhythmogenesis (14) (15) (16) (17) . We recently demonstrated in the canine ventricular wedge preparation that cooling to 26°C profoundly increases DOR, which could be directly linked to a mechanism of VF in severe hypothermia (18) . However, we also observed that mild hypothermia (MH) at temperatures typically used during TH was not associated with increases in DOR or arrhythmia susceptibility under normal, nonischemic conditions. The effects of hypothermia on DOR and conduction under global ischemic conditions, as seen during resuscitation from cardiac arrest, are unknown.
The arrhythmia substrates that occur during acute ischemia have been extensively studied (15) (16) (17) . Acute ischemia induces profound and complex electrophysiologic effects, resulting in increased transmural DOR. Ischemia also induces conduction slowing and conduction block. Transmural electrophysiologic hetero geneities and conduction block are fundamental to the mechanism of arrhythmias in ischemia (16, 17) . Objectives: Although the majority of sudden cardiac arrests occur in patients with ischemic heart disease, the effect of therapeutic hypothermia on arrhythmia susceptibility during acute global ischemia is not well understood. While both ischemia and severe hypothermia are arrhythmogenic, patients undergoing therapeutic hypothermia do not have an increase in arrhythmias, despite the fact that most sudden cardiac arrest occur in the setting of ischemia. We hypothesized that mild hypothermia induced prior to myocardial ischemia and reperfusion will have a beneficial effect on ischemia-related arrhythmia substrates.
Design: We developed a model of global ischemia and reperfusion in the canine wedge preparation to study the transmural electrophysiologic effects of ischemia at different temperatures.
Setting: Animal study. Subjects: Male mongrel dogs.
Interventions: Canine left ventricle wedge preparations at 1) control (36°C) or 2) mild hypothermia, to simulate temperatures used in therapeutic hypothermia (32°C), were subjected to 15 mins of no-flow ischemia and subsequently reperfused.
Measurements and Main Results: Optical action potentials were recorded spanning the transmural wall of left ventricle. Action potential duration for epicardial, mid-myocardial, and epicardial cells was measured. Transmural dispersion of repolarization and conduction velocity were measured at baseline, during ischemia, and during reperfusion. No difference was seen at baseline for conduction velocity or dispersion of repolarization between groups. Conduction velocity decreased from 0.46 ± 0.02 m/sec to 0.23 ± 0.07 m/sec, and dispersion of repolarization increased from 30 ± 5 msecs to 57 ± 4 msecs in the control group at 15 mins of ischemia. Mild hypothermia attenuated both the ischemia-induced conduction velocity slowing (decreasing from 0.44 ± 0.02 m/sec to 0.35 ± 0.03 m/sec; p = .019) and the ischemia-induced increase in dispersion of repolarization (25 ± 3 msecs to 37 ± 7 msecs; p = .037). epicardial conduction block was observed in six of seven preparations of the control group, but no preparations in the mild hypothermia group developed conduction block (0/6).
Conclusions: Mild hypothermia attenuated ischemia-induced increase in dispersion of repolarization, conduction slowing, and block, which are known mechanisms of arrhythmogenesis in ischemia. These data suggest that therapeutic hypothermia may decrease arrhythmogenesis during myocardial ischemia. (Crit Care Med 2012; 40:2954-2959) Key Words: arrhythmias; dispersion of repolarization; hypothermia; optical mapping; resuscitation; ventricular fibrillation
Mild hypothermia decreases arrhythmia susceptibility in a canine model of global myocardial ischemia*
As TH is more widely used, it is crucial to understand the interaction of a potentially arrhythmogenic therapy used in an arrhythmogenic situation. All patients with return of spontaneous circulation from a VF arrest undergo a period of global cardiac ischemia, but there are limited data on the electrophysiologic sequelae of TH in the postresuscitated heart or in ischemia-induced arrhythmias. This interaction is particularly important as the vast majority of VF arrests are caused by myocardial ischemia and infarction. Importantly, clinical and laboratory observations suggest that MH after cardiac arrest is not associated with an increase in arrhythmias (19) (20) (21) . It is possible that TH attenuates the substrate for ischemia-induced arrhythmias, specifically transmural DOR and transmural decreases in conduction velocity (CV). Better understanding of the mechanisms by which TH might be antiarrhythmic in the setting of acute ischemia may lead to 1) novel therapeutic targets to decrease ventricular arrhythmias both during ischemia and the postarrest patient, 2) refinement of TH protocols to optimize the potential cardioprotective effect of TH, and 3) the potential use of TH as a therapy in patients prior to cardiac arrest.
Our overall hypothesis is that MH induced during myocardial ischemia would be antiarrhythmic. Based on our previous studies in the nonischemic heart, we predicted that MH will attenuate the underlying electrophysiologic derangements that promote reentrant arrhythmias during ischemia: transmural conduction slowing and increased DOR. We used a model of global ischemia in the canine ventricular wedge preparation, which allows the study of transmural electrophysiologic effects of MH during ischemia and reperfusion.
MATERIALS AND METHODS
Study Design. Experiments were carried out in accordance with Public Health Service guidelines for the care and use of laboratory animals. Thirteen male mongrel dogs (~15-20 kg) were used in this study. Organ harvest by right lateral thoracotomy was performed under pentobarbital (50 mg/mL) intravenous general anesthesia, and the intact heart was rapidly excised. The details of our system for high-resolution transmural optical mapping of the arterial perfused canine wedge preparation were described previously (16, 18, (22) (23) (24) . In brief, wedges of myocardium surrounding secondary branches of the left anterior descending and circumflex were harvested from the left ventricle (~3 × 2 × 1.5 cm) and were isolated. The corresponding branch of coronary artery was cannulated and Langendorff perfused with Tyrode's solution (140 mM NaCl, 4.03 mM KCl, 1.8 mM CaCl 2 , 5.5 mM dextrose, 0.5 mM MgSO 4 , 0.9 mM NaH 2 PO 4 , 10 mM HEPES, NaOH titrated to a pH 7.41, and oxygenated with 100% O 2 ). The wedge was then placed in the chamber with the transmural surface against the glass imaging plate and perfused with an approximate perfusion pressure of 40 mm Hg and a perfusion rate of 12-20 mL/min. Pressure and rate were monitored throughout the experiment. Wedges were then perfused above Tyrode's solution and a voltage-sensitive dye (di-4-ANNEPS, 15 µM). Action potentials were recorded from 256 sites simultaneously with high spatial (0.89 mm), temporal (0.5 msecs), and voltage (0.5 mV) resolution. Optical magnification of ×1 to ×1.2 was used. Blebbistatin (5 µM) was used to eliminate motion artifact from the optical signals. We have previously validated a method for precise homogeneous temperature manipulation in the canine wedge preparation (18) . The imaging chamber was encased in a water insulated circuit, and temperature was measured using a digital temperature probe (Omega) in the water bath, allowing for temperature precision of 0.1°C. Temperature was controlled at 36°C (control group) or 32°C (MH group) prior to inducing ischemia so as to achieve and maintain specific temperature during the ischemia protocol.
Ischemia Protocol. We developed a model of global ischemia in the canine wedge preparations to evaluate the electrophysiologic effects of ischemia as seen in sudden cardiac arrest. To induce global ischemia, flow of oxygenated Tyrode's solution was stopped. Measurements were made at 5, 10, and 15 mins of no-flow ischemia. Flow was then resumed, and measurements were made at 5 and 10 mins of reperfusion.
Methods of Measurement. APD was measured by using an average of five epicardial (EPI), mid-myocardial, and endocardial (ENDO) cells. Transmural cell types were defined by previously validated anatomic and functional criterion (22) . EPI cells were defined as cells 1-2 mm from the EPI surface. ENDO cells were defined as cells 1-2 mm from the ENDO surface. Mid-myocardial cells were defined as the cells with the longest APD that were not EPI or ENDO cells. DOR was defined as the difference between the APD of the longest and shortest cell type. CV was determined by a previously validated vector analysis technique (25) .
For arrhythmia induction, an identical programmed electrical stimulation (PES) protocol was performed at baseline, during ischemia, and during reperfusion in five preparations of the control group and four preparations of the MH group in each group (23) . PES can induce conduction block, reentrant extra beats, monomorphic or polymorphic VT, and VF. VT was defined as three or more continuous extra beats. During ENDO pacing (S1), up to two premature beats were delivered from either the EPI or ENDO surface (S2 and S3), until failure to capture the preparation or an arrhythmia was induced. Typically, induced arrhythmias self-terminate in the wedge preparation allowing for serial comparison of arrhythmia susceptibility in any one preparation. PES was considered positive if there was a new inducible VT or VF from baseline or spontaneous VT or VF was observed. Baseline arrhythmias reproduced during ischemia were not considered positive.
Statistical analysis was performed using IBM SPSS Statistics 20 (IBM Corp, Armonk, NY). The primary analysis focused on the difference in electrophysiologic parameters between the MH and the control group at baseline and during ischemia. Student's t tests were used to analyze the differences in mean APD, CV, and DOR at baseline and at 15 mins of ischemia. Furthermore, to analyze the group-time from baseline to ischemia and then reperfusion as well as accounting for possible baseline differences between groups, repeated measure analysis of variance was performed with baseline covariate analysis and the EM algorithm (SAS Institute Inc, Cary, NC) for imputation of the minimal amount of missing data points through the trend (four of 78). Group effects and differences between specific means were considered significant with p ≤ .05. All mean data are represented with the value and standard error of the mean. Statistical significance for the figures is represented by an asterisk (*) or as otherwise stated in the figure legends.
RESULTS
MH Attenuates Ischemia-induced DOR and Preserves Action Potential Morphology. The effects of global ischemia on APD, action potential morphology, DOR, and conduction time (CT) are shown in a representative control experiment in Figure 1A . At baseline, DOR is 20 msecs, and repolarization gradient is minimal. During ischemia, CT is markedly slowed and the repolarization gradient increased. APD shortens, specifically in the epicardium with significant morphological changes demonstrating ischemia (triangulation of the action potential). DOR increases to 71 msecs. Upon reperfusion, APD morphology returns to baseline, CT improves, and DOR returns closer to baseline.
MH attenuated the electrophysiological effects of global ischemia, as shown in a representative experiment in Figure  1B . At baseline, there is similar DOR, CT, and repolarization gradient to the control experiment. During ischemia, the APD shortening seen in the control group is attenuated. CT is not significantly slowed, and the action potential morphology remained similar to baseline, specifically in the epicardium. The large ischemiainduced increase in DOR is attenuated. Upon reperfusion, DOR returns to baseline. Figure 2 summarizes the effect of MH on DOR during ischemia. At baseline, mean APD is longer in the hypothermia group (230 ± 6 msecs vs. 287 ± 7 msecs; p < .001) but no significant difference is seen in DOR (30 ± 5 msecs vs. 24 ± 3 msecs; p = ns). At 15 mins of ischemia, the increase in DOR is significantly larger in the control vs. MH group (57 ± 4 msecs vs. 37 ± 7 msecs; p = .037). Upon reperfusion, DOR returns to baseline and no significant difference is seen (p = ns). Table 1 summarizes the difference in mean APD and each cell type from baseline to ischemia. The greatest change is seen in the EPI cells (difference of 69 msecs) in the control group, which improved in the MH group (difference of 43 msecs).
MH Attenuates Ischemia-induced Conduction Slowing and EPI Conduction
Block. Conduction slowing was significantly attenuated during ischemia in the MH group. Figure 3 depicts isochrome maps of CT during ischemia and reperfusion in a representative example of both control and MH groups. In the control group, there is significant conduction slowing (crowding of isochrones) during ischemia with EPI conduction block (red line) that resolves during reperfusion. In the MH group, ischemia-induced conduction slowing is attenuated and no EPI block occurs. Figure 4 summarizes CV during ischemia reperfusion for both control and MH groups. At baseline, no significant difference in CV was appreciated 0.46 ± 0.02 m/sec vs. 0.44 ± 0.02 m/sec; p = ns). At 15 mins of ischemia, there was a significantly greater decrease in CV in the control group (0.23 ± 0.07 m/sec vs. 0.35 ± 0.03 m/sec; p = .019). Both groups returned to baseline upon rewarming.
EPI conduction block was improved by MH. In six of seven preparations in the control group, conduction block in the EPI was observed, while we did not observe EPI conduction block in any of the MH group (0/6 preparations).
Programmed Electrical Stimulation. Five preparations in the control group and four in the MH group underwent PES. In the control group, three of five had a positive PES during ischemia. VT was induced in two preparations at the area of conduction block, and one preparation had spontaneous VT at 15 mins of ischemia. In the MH group, one of four preparations had a new arrhythmia during ischemia and there was no evidence of EPI block. In the preparation that was inducible, the VT origin was not related to transmural conduction slowing or block. Figure 5 depicts an arrhythmia induced during PES, resulting from EPI conduction block in the control group during ischemia.
DISCUSSION
These data demonstrate that MH, as induced during TH, attenuates the underlying electrophysiologic derangements that promote reentrant arrhythmias during ischemia. MH attenuates transmural conduction slowing and increased DOR, protecting against ischemia-induced arrhythmias and providing potential insights into the mechanisms underlying this protection.
Clinically, TH has not been shown to increase arrhythmias, despite a potentially arrhythmic treatment (hypothermia) being added to an already arrhythmogenic substrate (ischemia). Sagalyn et al (20) reviewed 13 studies of patients undergoing TH after return of spontaneous circulation from cardiac arrest. Of the 656 patients treated with TH, 11% had an arrhythmia vs. 30% (41/138) in the historical controls.
Results of studies to assess the potential cardioprotective benefit of TH in MI prior to arrest have been mixed. Two clinical trials did not demonstrate a reduction figure 1. Mild hypothermia (MH) attenuates ischemia-induced derangements in action potential duration, con duction time, and repolarization gradients. A, Representative action potentials from each cell type during ischemia and reperfusion from the control group are shown. Electrocardiography (ECG) is also shown. Left, Action potentials at baseline demonstrate a baseline dispersion of 20 msecs. Middle, During ischemia, marked pro longation of dispersion is observed, secondary to significant epicardial (EPI) action potential duration shortening. Right, After 10 mins of reperfusion, dispersion, and action potential duration returns toward baseline. B, Representative action potentials during ischemia and reperfusion from the MH group are shown. ECG is also shown. Left, Action potentials at baseline. Middle, During ischemia, EPI shortening is attenuated. Right, After 10 mins of reperfusion, dispersion returns to baseline. ENDO, endocardial; DOR, dispersion of repolarization.
in infarct size or improvement of ejection fraction (26, 27) . However, subgroup analysis of patients undergoing TH before revascularization showed a possible benefit. Therefore, a recent feasibility study was performed to enroll patients in a clinical trial to assess this new question (28) . Importantly, none of these studies demonstrated an increase in ventricular arrhythmias during hypothermia. Although the number of patients in these studies was small and the study aims addressed infarct size and cardiac function, the number of arrhythmias reported was less in the hypothermia groups.
Ischemia-induced conduction slowing was improved by MH. A possible explanation for this observation is that MH maintained intercellular communication through gap junctions during ischemia, thereby maintaining conduction. Another possible mechanism includes temperature-related preservation of ischemia-sensitive conduction currents, specifically the fast Na current. We also observed that MH attenuated ischemiainduced enhancement of DOR. It is likely that one or more temperature-sensitive repolarization currents are affected by hypothermia. I K,ATP is a temperaturesensitive repolarization current that is activated by ischemia and attenuated by hypothermia. It is therefore possible that hypothermia prevented activation of this current, maintaining APD and DOR, and therefore playing a role in the beneficial effects of MH observed in these studies. It is also possible that decreasing ATP utilization during hypothermia had a beneficial effect of CV and repolarization time.
At this time, the only therapy directly treating the postarrest patient is TH, based on studies demonstrating improved neurological outcome and survival benefit. Exploring potential mechanisms of benefit could provide insight not only into the improved morbidity and mortality observed with TH but potentially the development of novel antiarrhythmic interventions during resuscitation as well as in patients suffering from ongoing ischemia.
These experiments have some limitations. First, electrophysiologic effects of hypothermia were evaluated only using optical mapping in the canine wedge preparation and therefore in a twodimensional area of a small portion of the left ventricle. Therefore, we cannot account for changes in interventricular conduction or repolarization or other Inducible, induced with programmed electrical stimulation (PES); spontaneous, occurred during observation without PES. Temperature noted is where arrhythmia was first induced or observed during cooling or rewarming protocol. Block and reentry, conduction block and single reentrant beat mapped during PES. All ventricular fibrillation was nonsustained polymorphic unless otherwise noted. All arrythmias resolved spontaneously. heterogeneities (such as apex to base heterogeneities), which could potentially play a role in arrhythmia susceptibility in a whole-heart model of global ischemia. However, two important mechanisms of arrhythmias, transmural CV and transmural dispersion or repolarization, are best studied using the transmural canine wedge model. Further studies in wholeheart models of resuscitation are warranted. Second, our protocols dictated that the MH group hypothermia was instituted at 32°C before the preparation was made ischemic and does not directly simulate the clinical scenario where TH is induced soon after the onset of ischemia. We specifically chose this design to directly evaluate the effect of temperature on global ischemia, and the time required to cool the canine wedge preparation to TH levels (longer than 15 mins) exceeds the time that the canine wedge preparation remains viable during global ischemia. Because there is likely ongoing ischemia during most cases of clinical resuscitation as well as near-immediate cooling by EMS in many clinical TH protocols, we feel this model is clinically relevant. Future studies in models of low-flow or less severe ischemia and induction of TH are warranted. Although out of the scope of the current investigation, we also did not directly examine the potential mechanisms underlying the beneficial electrophysiological effect of MH. Although these studies provide insight into potential antiarrhythmic effects of TH in ischemic myocardium, further studies will be required to determine the cellular and molecular basis for the protective effects observed.
CONCLUSIONS
MH, at temperatures similar to TH, may decrease arrhythmia susceptibility by preserving transmural CV while attenuating EPI conduction block and increases in DOR, suggesting that TH may be antiarrhythmic in the ischemic myocardium. With the greater adoption of TH, an improved understanding of the electrophysiologic effects of TH on arrhythmogenesis in the ischemic and postresuscitated heart is of growing importance. These data suggest that improved understanding of the interaction between myocardial ischemia and TH may provide avenues for the development of new therapies in the postarrest patient. figure 4. Mild hypothermia (MH) attenuates conduction slowing. Summary data are shown for MH and control groups during ischemia and reperfusion. No difference in conduction velocity was seen at baseline. Significant increase is seen at 15 mins of ischemia in the control group compared to MH group (denoted by *). Overall group by time difference was significant (p = .027).
figure 5. Arrhythmia secondary to conduction block during ischemia. A, Electrocardiography and action potentials during programmed electrical stimulation are shown. Three endocardial (ENDO) paced beats (S1, S2, and S3) are followed by induction of ventricular tachycardia. B, Activation mapping before ischemia compared to 15 mins of ischemia (S1 beat). Note that ischemia induces significant conduc tion slowing (crowding of isochrones). During ischemia, conduction fails in the epicardium (area with dashed line). Conduction block occurs during the S3 beat (block symbol in A, line in B) followed by the initiation of ventricular tachycardia (VT), with the first beat reentering through the more electrically preserved subepicardium.
